Insulin modulation of newly synthesized apolipoproteins B-100 and B-48 in human fetal intestine: gene expression and mRNA editing are not involved

FEBS Lett. 1996 Sep 16;393(2-3):253-8. doi: 10.1016/0014-5793(96)00896-4.

Abstract

We investigated insulin's effect on intestinal lipid, transport and, particularly, the biogenesis of apolipoproteins crucial to lipoprotein secretion. Adding insulin (3 mU) to the serum-free medium of cultured jejunal explants from human fetuses (17-20 weeks) reduced triglyceride and chylomicron production and inhibited apo B-48 and apo B-100 secretion. When apo B mRNA was assayed by RT-PCR and its editing by primer extension, no change was detectable following the addition of insulin. HDL lipid content, apo A-1 synthesis and RNA level were unaffected by insulin. Collectively, these results suggest that the insulin-stimulated decline in intestinal chylomicron output may involve apo B co- or post-translational modifications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Induced
  • Apolipoprotein A-I / biosynthesis
  • Apolipoprotein B-100
  • Apolipoprotein B-48
  • Apolipoproteins B / biosynthesis*
  • DNA Primers
  • Embryo, Mammalian
  • Female
  • Fetus
  • Gene Expression*
  • Gestational Age
  • Humans
  • Insulin / pharmacology*
  • Jejunum / drug effects
  • Jejunum / embryology
  • Jejunum / metabolism*
  • Lipid Metabolism
  • Lipoproteins / biosynthesis
  • Organ Culture Techniques
  • Polymerase Chain Reaction
  • Pregnancy
  • RNA Editing*

Substances

  • Apolipoprotein A-I
  • Apolipoprotein B-100
  • Apolipoprotein B-48
  • Apolipoproteins B
  • DNA Primers
  • Insulin
  • Lipoproteins